% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Teske:305537,
author = {N. Teske$^*$ and A. Dono and J. S. Young and S. T. Juenger
and G. C. Youssef and L. Häni and T. Sciortino and F. Bruno
and J. Dietrich and C. Y. Mau and M. Weller and J. Beck and
S. Hervey-Jumper and A. M. Molinaro and S. M. Chang and M.
van den Bent and M. A. Vogelbaum and M. I. Ruge and D. P.
Cahill and R. Rudà and L. Bello and S. J. Grau and O.
Schnell and R. Y. Huang and P. Y. Wen and N. Tandon and M.
S. Berger and J.-C. Tonn$^*$ and Y. Esquenazi and P.
Karschnia$^*$},
title = {{A}ssociations of supramaximal resection with outcome in
glioblastoma across age groups: a report of the {RANO}
resect group.},
journal = {Neuro-Oncology},
volume = {nn},
issn = {1522-8517},
address = {Oxford},
publisher = {Oxford Univ. Press},
reportid = {DKFZ-2025-02211},
pages = {nn},
year = {2025},
note = {epub},
abstract = {The oncological role of resection in elderly patients with
glioblastoma remains controversial. We evaluated the value
of resection in patients ≥65 years with (I) newly
diagnosed and (II) recurrent glioblastoma by comparing the
prognostic relevance of extent of resection to patients <65
years.The international RANO resect group retrospectively
collected patients with newly diagnosed and recurrent
IDH-wildtype glioblastoma from ten neuro-oncological
centers. Associations of residual tumor with molecular and
clinical markers and survival were analyzed.1260 patients
with newly diagnosed glioblastoma were identified, including
512 patients ≥65 years. Lower postoperative
contrast-enhancing tumor volumes were favorably associated
with survival on uni- and multivariate analyses; however,
the associations with outcome were more pronounced in
younger patients. Only in patients <65 years, supramaximal
resection was associated with more favorable survival (40
vs. 20 months, p=0.001). In 310 patients with first
recurrence (≥65 years: 92), maximal resection of
contrast-enhancing tumor was associated with favorable
outcomes, particularly in younger patients. Neither older
nor younger patients had favorable outcome associations of
supramaximal resection in the recurrent setting. All
findings were confirmed in propensity-score-matched analyses
to minimize confounding effects of inherent differences in
demographic and clinical markers (including second-line
treatments) between older and younger patients.While
complete contrast-enhancing tumor resection is prognostic
for favorable outcomes in older patients, associations of
supramaximal resection with improved outcomes were only
retained in younger patients with newly diagnosed disease.
Those findings support stratified surgical approaches.},
keywords = {extent of resection (Other) / glioblastoma (Other) /
outcome (Other) / patient stratification (Other) / surgery
(Other)},
cin = {MU01},
ddc = {610},
cid = {I:(DE-He78)MU01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41137668},
doi = {10.1093/neuonc/noaf239},
url = {https://inrepo02.dkfz.de/record/305537},
}